Sarasa MNL, Cruz PB, Artiles SA

Language: Spanish
References: 9
Page: 192-197
PDF size: 284.56 Kb.

ABSTRACT

Obesity in pregnant women is a complex disease that can lead to further metabolic disorders; however increased adipose tissue can also occur in pregnant women of normal body weight. The objective of this communication was to reflect on the dangers of the obesity trinomial epidemic, insulin resistance and type 2 diabetes, for new generations and public health in general. The effects of excess adiposity in pregnant women were analyzed, through the changes in placental transport in the "reprogramming" of cellular energy metabolism, and its incidence on different tissues, which can cause insulin resistance and type 2 diabetes. We concluded that the awareness of the danger posed by obesity, even when it is overlapping, demands the stratification of its risk based on adiposity rather than body weight of patients.

REFERENCES

1. Miazgowski T, Sołtysiak M, Katarzyna Ossowska K, Kaczmarkiewicz A. The civilization-related phenotypes of abnormal fatty tissue distribution: visceral obesity and sarcopoenic obesity. Arterial Hypertens. 2015;19(1):1-8.

2. World Health Organization. Global Status Report on Noncommunicable Diseases 2014. Geneva: WHO; 2014.

3. Desai M, Jellyman JK, Han G, Beall M, Lane RH, Ross MG. Maternal obesity and high-fat diet program offspring metabolic syndrome. Am J Obstet Gynecol. 2014 Sep.;211(3):237:e1-237.e13.

4. Lavie CJ, Milani RV, Ventura HO. Obesity and the “Obesity Paradoxˮ in Cardiovascular Diseases. Clin Pharmacol Ther. 2011 May 11;90(1):23-5.

5. Guerendiain M. Impacto de la obesidad materna sobre la programación metabólica fetal. Rev Fac Med. 2015;18(4):147-51.

6. Ryo M, Kishida K, Nakamura T, Yoshizumi T, Funahashi T, Shimomura L. Clinical significance of visceral adiposity assessed by computed tomography: A Japanese perspective. World J Radiol. 2014 Jul. 28;6(7):409-16.

7. Nicholas LM, Morrison JL, Rattanatray L, Zhang S, Ozanne SE, McMillen IC. The early origins of obesity and insulin resistance: timing, programming and mechanisms. Int J Obes (Lond) [internet]. 2015 Sep. 14 [citado 19 jul. 2018];40(2):[aprox. 10 p.]. Disponible en: https://www.nature.com/articles/ijo2015178

8. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. Lancet [internet]. 1993 Apr. [citado 19 jul. 2018];341(8850):[aprox. 4 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/8096277

9. Molina Giraldo S, Correa Mendoza DM, Rojas Arias JL, Acuña Osorio E. Orígenes fetales de la patología del adulto: la restricción del crecimiento intrauterino como factor de riesgo. Rev Chil Obstet Ginecol [internet]. 2014 [citado 19 jul. 2018];79(6):[aprox. 8 p.]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262014000600014